Call 888-647-0579 to speak with an alcohol or drug abuse counselor.

Who Answers?

Cancer Immunotherapy Shows Long-Term Promise In Lung Cancer

New, long-term results from a clinical trial presented today at the 1st European Lung Cancer Conference jointly organized by the European Society for Medical Oncology (ESMO) and the International Association of the Study of Lung Cancer (IASLC) show that MAGE-A3 ASCI (Antigen-Specific Cancer Immunotherapeutic), an immune-boosting treatment for lung cancer patients, reduces the risk of relapse after surgery — to the same extent as chemotherapy but without the side-effects of chemotherapy.

Prof. Johan Vansteenkiste from University Hospital Gasthuisberg in Belgium described the results after 44-months follow-up from a double-blind, placebo-controlled trial in 182 patients with non-small-cell lung cancer — the most common form of the disease.

After complete surgical resection of the tumor, patients were randomly assigned to receive either placebo injections or injections of MAGE-A3 ASCI administered over 27 months (five given at three-week intervals followed by eight given once every three months).

MAGE-A3 is a tumor-specific antigen, expressed in 35-50% of non-small-cell lung cancer, but not on normal cells.

“The aim is to help the body immune system to recognize the MAGE-A3 antigen and therefore eliminate the cancer cells that express MAGE-A3,” explains Prof. Vansteenkiste. “In other words, it is a kind of treatment method that makes the body immune system specifically attack the lung cancer cells.”

After 44 months, 69 of 182 patients had experienced a recurrence of their cancer, including 57 deaths. Those given the MAGE-A3 injections had longer on average before their cancer recurred, were less likely to have any recurrence, and were less likely to die.

“Surgical resection is the standard treatment for patients with early stage lung cancer, but after complete resection about 50% will relapse and die from their cancer,” says Prof. Vansteenkiste. “Postoperative chemotherapy is able to improve cure rates, but is sometimes poorly tolerated by patients recovering from thoracic surgery. In addition, not all patients are fit to receive chemotherapy. This is why the signal from this phase II randomized study is important: the reduction in risk of postoperative cancer relapse is similar to the one obtained with postoperative chemotherapy, while the side-effects of this new strategy are minimal compared to chemotherapy.”

Most patients only experience mild reactions at the injection site and fever within 24 hours of the injection, he explained. “Therefore, it is suitable for long-term maintenance treatment and for most patients, including older patients or patients in weak physical condition after surgery, allowing them to live a normal life whilst on cancer treatment.” A large Phase III trial of the therapy, named MAGRIT, is now underway.

source: http://www.esmo.org/

More Treatment & Detox Articles

Sight damaged by too much beer

Knocking back four beers a day doesn’t just risk a serious beer gut – it could also be damaging your eyesight, a study of Australian men has found. Melbourne research shows men in their 60s who drink alcohol heavily are about six times more likely to develop the most debilitating form of age-related macular degeneration….

Alcohol, When Enough Is Enough

Not all alcohol abusers look or act alike. Nor do they start on the road to alcoholism the same way or share the same set of problems. What they have in common is that they are all, in some way, damaging their lives. There are many ways to be diagnosed as being alcohol dependent. Alcohol….

Study shows teen drinking rates getting worse

If you have children between the ages of 12 and 20, you might want talk to them about the dangers of underage drinking. A new study released from the Federal Substance Abuse and Mental Health Services Administration says more kids are drinking at a younger age because their parents aren’t educating them enough about the….

Paris fights binge-drinking

A new campaign by Mayor Bertrand Delanoe tries to persuade young Parisians to shun the fashion for drinking themselves to oblivion at weekends. France used to look down on the British habit of getting smashed and staggering in a stupor through the streets but now it is happening here. For the past couple of years,….

Alcohol a ‘major contributing factor’ in self harm

Alcohol was involved in nearly two thirds of self harm cases which were recorded as part of a pilot programme in the Western Health Trust area. The “Registry of Deliberate Self Harm” recorded almost 2,700 incidents between January 2007 and December 2008. The A&E units of Altnagelvin, Tyrone County and Erne Hospitals took part. The….